Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Ausceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2181-2184

  Antonopoulou, Stavroula ^a,b,d   Aoun, Michel ^b   Alexopoulos, Evangelos C ^c   Baka, Stavroula ^a   Logothetis, Emanuel ^a   Kalambokas, Theodoros ^a,d   Zannos, Andreas ^d,e   Papadias, Konstantine ^a   Grigoriou, Odysseas ^a   Kouskouni, Evangelia ^a   Velegraki, Aristea ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b JULES BORDET INSTITUTE   (Belgium)

^c UNIVERSITY OF PATRAS   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e Military Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FENTICONAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CORRELATION COEFFICIENT; EUROPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VULVOVAGINITIS;

ADULT; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, VULVOVAGINAL; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG RESISTANCE, FUNGAL; EUROPE; FEMALE; FLUCONAZOLE; GENOTYPE; HUMANS; IMIDAZOLES; ITRACONAZOLE; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE;

EID: 66149101594     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01413-08     Document Type: Article

References (35)

1. Alcoba-Flórez, J., M. del Pilar Arévalo, F. J. González-Paredes, J. Cano, J. Guarro, E. Pérez-Roth, and S. Méndez-Álvarez. 2005. PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast. J. Clin. Microbiol. 43:6194-6196.
2. Arrese, J. E., L. Fogouang, C. Piérard-Franchimont, and G. E. Piérard. 2002. Euclidean and fractal computer-assisted corneofungimetry: a comparison of 2% ketoconazole and 1% terbinafine topical formulations. Dermatology 204:222-227. (Pubitemid 34628312)
3. Bikandi, J., R. San Millán, M. D. Moragues, G. Cebas, M. Clarke, D. C. Coleman, D. J. Sullivan, G. Quindós, and J. Pontón. 1998. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J. Clin. Microbiol. 36:2428-2433. (Pubitemid 28380931)
4. Centers for Diseases Control and Prevention, K. A. Workowski, and S. M. Berman. 2006. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recommend. Rep. 55:1-94.
5. Chong, P. P., P. Sampaio, L. Gusmão, C. Alves, C. Pina-Vaz, A. Amorim, and C. Pais. 2003. Highly polymorphic microsatellite for identification of Candida albicans strains. J. Clin. Microbiol. 41:552-557.
6. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; third informational supplement. Document M27-S3. CLSI, Wayne, PA.
7. das Neves, J., E. Pinto, B. Teixeira, G. Dias, P. Rocha, T. Cunha, B. Santos, M. H. Amaral, and M. F. Bahia. 2008. Local treatment of vulvovaginal candidosis: general and practical considerations. Drugs 68:1787-1802.
8. De Bernardis, F., and A. Cassone. 1996. Comparison of the effects of fenticonazole and econazole on the aspartic proteinase secreted by Candida albicans. Contracept. Fertil. Sex. 24:163-165. (Pubitemid 26081863)
9. Dodgson, A. R., C. Pujol, D. W. Denning, D. R. Soll, and A. J. Fox. 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J. Clin. Microbiol. 41:5709-5717.
10. European Committee for Antimicrobial Susceptibility Testing (EUCAST) Subcommittee on Antifungal Susceptibility Testing (AFST). 2008. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. 2008. Clin. Microbiol. Infect. 14:398-405.
11. European Committee for Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). 2008. Technical note on fluconazole. Clin. Microbiol. Infect. 14:193-195.
12. Fernández-Alba, J., A. Valle-Gay, M. Dibildox, J. A. Vargas, J. González, M. García, L. H. López, and the Fentimex Mexican Study Group. 2004. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen. J. Chemother. 16:179-186.
13. Fidel, P. L., Jr. 2005. Immunity in vaginal candidiasis. Curr. Opin. Infect. Dis. 18:107-111.
14. Fundyga, R. E., T. J. Lott, and J. Arnold. 2002. Population structure of Candida albicans, a member of the human flora, as determined by microsatellite loci. Infect. Genet. Evol. 2:57-68.
15. Gaitanis, G., A. Velegraki, E. C. Alexopoulos, E. Kapsanaki-Gotsi, L. Zisova, Y. Ran, H. Zhang, G. Arsenis, I. D. Bassukas, and J. Faergemann. 20 November 2008, posting date. Malassezia furfur fingerprints as possible markers for human phylogeography. ISME J. doi:10.1038/ismej.2008.112.
16. Gräser, Y., M. Volosek, J. Arrington, G. Schonian, W. Presber, T. G. Mitchell, and R. Vilgalys. 1996. Molecular markers reveal that population structure of the human pathogen Candida albicans exhibits both clonality and recombination. Proc. Natl. Acad. Sci. USA 93:12473-12477.
17. Kent, H. L. 1991. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 165:1168-1175.
18. Kurzai, O., W. J. Heinz, D. J. Sullivan, D. C. Coleman, M. Frosch, and F. A. Mühlschlegel. 1999. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J. Clin. Microbiol. 37:1587-1590. (Pubitemid 29187843)
19. Linton, C. J., A. M. Borman, G. Cheung, A. D. Holmes, A. Szekely, M. D. Palmer, P. D. Bridge, C. K. Campbell, and E. M. Johnson. 2007. Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United Kingdom Mycology Reference Laboratory. J. Clin. Microbiol. 45:1152-1158. (Pubitemid 46626478)
20. Liu, X. P., S. R. Fan, F. Y. Bai, J. Li, and Q. P. Liao. 2009. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis. Mycoses 52:24-28.
21. Manferdi, M., M. J. McCullough, L. Polonelli, S. Conti, Z. M. Al-Karaawi, P. Vescovi, and S. R. Porter. 2006. In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol. Immunol. 21:177-182.
22. Marrazzo, J. 2002. Vulvovaginal candidiasis. Clin. Evid. 7:1784-1796.
23. Meyer, W., and T. G. Mitchell. 1995. Polymerase chain reaction fingerprinting in fungi using single primers specific to minisatellites and simple repetitive DNA sequences: strain variation in Cryptococcus neoformans. Electrophoresis 16:1648-1656.
24. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. NCCLS, Wayne, PA.
25. Nurbhai, M., J. Grimshaw, M. Watson, C. Bond, J. Mollison, and A. Ludbrook. 2007. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst. Rev. 4:CD002845.
26. Odds, F. C., M. E. Bougnoux, D. J. Shaw, J. M. Bain, A. D. Davidson, D. Diogo, M. D. Jacobsen, M. Lecomte, S. Y. Li, A. Tavanti, M. C. Maiden, N. A. Gow, and C. d'Enfert. 2007. Molecular phylogenetics of Candida albicans. Eukaryot. Cell 6:1041-1052.
27. Quaglia, M. G., E. Donati, N. Desideri, S. Fanali, F. D. D'auria, and M. Tecca. 2002. Chiral discrimination by HPLC and CE and antifungal activity of racemic fenticonazole and its enantiomers. Chirality 5:449-454.
28. Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, and J. E. Edwards. 2000. Practice guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30:662-678.
29. Rodriguez-Tudela, J. L., J. P. Donnelly, M. A. Pfaller, E. Chryssantou, P. Warn, D. W. Denning, A. Espinel-Ingroff, F. Barchiesi, and M. Cuenca-Estrella. 2007. Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2). J. Clin. Microbiol. 45:109-111.
30. Sobel, J. D. 2007. Vulvovaginal candidosis. Lancet 369:1961-1971. (Pubitemid 46874580)
31. Staib, P., and J. Morschhaüser. 1999. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 42:521-524.
32. Takakura, S., S. Ichiyama, J. M. Bain, A. D. Davidson, M. D. Jacobsen, D. J. Shaw, N. A. Gow, and F. C. Odds. 2008. Comparison of Candida albicans strain types among isolates from three countries. Int. J. Med. Microbiol. 298:663-668.
33. Tavanti, A., A. D. Davidson, M. J. Fordyce, N. A. R. Gow, M. C. J. Maiden, and F. C. Odds. 2005. Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J. Clin. Microbiol. 43:5601-5613.
34. Velegraki, A., M. Kambouris, A. Kostourou, G. Chalevelakis, and N. J. Legakis. 1999. Rapid extraction of fungal DNA from clinical samples for PCR amplification. Med. Mycol. 37:69-73. (Pubitemid 29110247)
35. Xu, J., C. M. Boyd, E. Livingston, W. Meyer, J. F. Madden, and T. G. Mitchell. 1999. Species and genotypic diversities and similarities of pathogenic yeasts colonizing women. J. Clin. Microbiol. 37:3835-3843.